Can potential hazard of Creutzfeldt-Jakob disease infectivity be reduced in the production of human Growth Hormone?
- 1 March 1988
- journal article
- research article
- Published by Springer Nature in Archiv für die gesamte Virusforschung
- Vol. 98 (1-2) , 131-135
- https://doi.org/10.1007/bf01321014
Abstract
Scrapie infectivity is reduced 5–6 logs following filtration through 100,000 MW cut-off filter plus overnight treatment with 6 M urea. These steps, applied to purified human Growth Hormone (hGH), increase the margin of safety of hGH.This publication has 16 references indexed in Scilit:
- Newer Data on the Inactivation of Scrapie Virus or Creutzfeldt-Jakob Disease Virus in Brain TissueThe Journal of Infectious Diseases, 1986
- VIRUS STERILITY FOR HUMAN GROWTH HORMONEThe Lancet, 1985
- Potential Epidemic of Creutzfeldt–Jakob Disease from Human Growth Hormone TherapyNew England Journal of Medicine, 1985
- PREPARATION OF GROWTH HORMONE FREE FROM CONTAMINATION WITH UNCONVENTIONAL SLOW VIRUSESThe Lancet, 1985
- Prions: Novel Infectious PathogensPublished by Elsevier ,1984
- LARGE-SCALE PREPARATION OF HIGHLY PURIFIED PYROGEN-FREE HUMAN GROWTH HORMONE FOR CLINICAL USEJournal of Endocrinology, 1979
- Characteristics of a Short Incubation Model of Scrapie in the Golden HamsterJournal of General Virology, 1977
- DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERYThe Lancet, 1977
- Course of Experimental Scrapie Virus Infection in the GoatThe Journal of Infectious Diseases, 1974
- Further Studies on ScrapieJournal of Comparative Pathology and Therapeutics, 1959